Do nanoparticles pass the intestinal barrier? Transport studies in vitro and ex vivo

被引：0
|
作者：
Hesler, Michelle [1 ]
Meier, Florian [2 ]
Kohl, Yvonne [1 ]
机构：
[1] Fraunhofer Inst Biomed Engn IBMT, Sulzbach, Germany
[2] Postnova Analyt GmbH, Landsberg, Germany
来源：
TOXICOLOGY LETTERS | 2017年 / 280卷
关键词：
D O I：
10.1016/j.toxlet.2017.07.530
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P-05-03-26
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [1] Xanthones as potential P-glycoprotein modulators at the intestinal barrier: in vitro and ex vivo studies
    Silva, V. L. S.
    Silva, R.
    Gil-Martins, E.
    Sousa, E.
    Resende, D.
    Remiao, F.
    Rocha-Pereira, C.
    [J]. TOXICOLOGY LETTERS, 2019, 314 : S93 - S94
  • [2] In Vitro and in Vivo Studies on the Transport of PEGylated Silica Nanoparticles across the Blood-Brain Barrier
    Liu, Dan
    Lin, Bingqian
    Shao, Wei
    Zhu, Zhi
    Ji, Tianhai
    Yang, Chaoyong
    [J]. ACS APPLIED MATERIALS & INTERFACES, 2014, 6 (03) : 2131 - 2136
  • [3] An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers
    Xu, Yining
    Shrestha, Neha
    Preat, Veronique
    Beloqui, Ana
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2021, 175
  • [4] Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies
    Kesavan Bhaskar
    Jayaraman Anbu
    Velayutham Ravichandiran
    Vobalaboina Venkateswarlu
    Yamsani Madhusudan Rao
    [J]. Lipids in Health and Disease, 8
  • [5] Toxicological Assessment of Inhaled Nanoparticles: Role of in Vivo, ex Vivo, in Vitro, and in Silico Studies
    Froehlich, Eleonore
    Salar-Behzadi, Sharareh
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (03) : 4795 - 4822
  • [6] Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies
    Bhaskar, Kesavan
    Anbu, Jayaraman
    Ravichandiran, Velayutham
    Venkateswarlu, Vobalaboina
    Rao, Yamsani Madhusudan
    [J]. LIPIDS IN HEALTH AND DISEASE, 2009, 8
  • [7] Variants of β-casofensin, a bioactive milk peptide, differently modulate the intestinal barrier: In vivo and ex vivo studies in rats
    Bruno, Jeremie
    Nicolas, Aurelie
    Pesenti, Sandra
    Schwarz, Jessica
    Simon, Jean-Luc
    Leonil, Joelle
    Plaisancie, Pascale
    [J]. JOURNAL OF DAIRY SCIENCE, 2017, 100 (05) : 3360 - 3372
  • [8] A contribution to safety assessment of veterinary drug residues:: in vitro/ex vivo studies on the intestinal toxicity and transport of covalently bound residues
    Klee, S
    Baumung, I
    Kluge, K
    Ungemach, FR
    Horne, E
    O'Keeffe, M
    De Angelis, I
    Vignoli, AL
    Zucco, F
    Stammati, A
    [J]. XENOBIOTICA, 1999, 29 (06) : 641 - 654
  • [9] How I do . . . ex vivo in vitro maturation?
    Neyroud, A. -S.
    Guez-Loussouarn, C.
    Bales, D.
    Rives-Lange, C.
    Leveque, J.
    Duros, S.
    [J]. GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2020, 49 (04): : 292 - 295
  • [10] Ex Vivo Studies on the Distribution and Penetration of mPEG-PLGA Nanoparticles in the Intestinal Mucosa of Rats
    Lin, Donghai
    Li, Gang
    Qin, Lifang
    Wen, Zhen
    Wang, Junteng
    [J]. NANOSCIENCE AND NANOTECHNOLOGY LETTERS, 2014, 6 (11) : 1024 - 1029
12345